Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Nsclc Advanced'

Nsclc Advanced published presentations and documents on DocSlides.

SW GLH services for NSCLC – An update

SW GLH services for NSCLC – An update

  • everly
  • 14 Slides

Professor Rachel Butler. The genomic complexity of...

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

  • sawyer742
  • 5 Slides

Intervista a Federico . Cappuzzo. Background:. Pr...

Michael

Michael

  • luanne-stotts
  • 62 Slides

Brada. . Torino. . 6 March 2015. Perspectives...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

  • debby-jeon
  • 30 Slides

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

Thierry

Thierry

  • cheryl-pisano
  • 40 Slides

Le Chevalier, . MD. The Role of Translational Res...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

  • ellena-manuel
  • 48 Slides

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

NSCLC with high PD-L1 expression on tumor cells or tumor-in

NSCLC with high PD-L1 expression on tumor cells or tumor-in

  • test
  • 5 Slides

Intervista a Federico . Cappuzzo. Background:. P...

James Yang,

James Yang,

  • pasty-toler
  • 93 Slides

MD. The Evolving Treatment Landscape in NSCLC: Co...

Comparision

Comparision

  • jane-oiler
  • 33 Slides

of the expression of . 17-beta-hydroxysteroid . ...

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

  • pasty-toler
  • 0 Slides

This program will include a discussion of off-lab...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

  • luanne-stotts
  • 25 Slides

The Role of Antiangiogenic Agents in the Changin...

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

  • stefany-barnette
  • 15 Slides

The Cancer genome atlas (TCGA) and the search for...

Please note, these are the

Please note, these are the

  • disclaimercanon
  • 72 Slides

actual. . video-recorded proceedings from the . l...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

  • chaptoe
  • 71 Slides

proceedings from the live CME event and may includ...

NSCLC: Epidemiology and disease characteristics

NSCLC: Epidemiology and disease characteristics

  • scarlett
  • 15 Slides

NSCLC, non-small cell lung cancer.. Lung cancer in...

Multidisciplinary approach to lung cancer

Multidisciplinary approach to lung cancer

  • elena
  • 65 Slides

Kamil Konopka. Department of Oncology, University ...

Consensus or Controversy?  

Consensus or Controversy?  

  • okelly
  • 109 Slides

Addressing Practical Clinical Questions Across the...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

  • karlyn-bohler
  • 51 Slides

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Slides last updated:

Slides last updated:

  • calandra-battersby
  • 7 Slides

October 2013. There are two main types of lung . ...

Lung malignancy

Lung malignancy

  • tawny-fly
  • 17 Slides

Dr. Rachel Cary, FY1 Warwick Hospital. Learning ...

Targeting KRAS and down streaming

Targeting KRAS and down streaming

  • alexa-scheidler
  • 51 Slides

pathways. Federico Cappuzzo. Istituto Toscano Tum...

Terapia

Terapia

  • min-jolicoeur
  • 40 Slides

targeted. : . limiti e successi nelle metastasi ...

Detection of Mutations in EGFR in Circulating Lung-Cancer C

Detection of Mutations in EGFR in Circulating Lung-Cancer C

  • sherrill-nordquist
  • 12 Slides

Colin Reisterer and Nick Swenson. S. . Maheswaran...

Second line

Second line

  • alida-meadow
  • 66 Slides

treatments. in WT . pts. : . which. . opportuni...

Slides last updated:

Slides last updated:

  • stefany-barnette
  • 25 Slides

October 2013 . Ferlay . J, Shin HR, Bray F, Forma...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

  • pamella-moone
  • 51 Slides

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Italian cohort of

Italian cohort of

  • test
  • 3 Slides

nivolumab. Expanded Access . Programme. (EAP): ...

Minesh Mehta, Northwestern University

Minesh Mehta, Northwestern University

  • mitsue-stanley
  • 40 Slides

Chicago, IL. Radiation for Prevention and Treatme...

Optimal treatment for elderly patients with NSCLC

Optimal treatment for elderly patients with NSCLC

  • cheryl-pisano
  • 43 Slides

Giorgio V. Scagliotti. University. of . Torino,....

L’algoritmo terapeutico

L’algoritmo terapeutico

  • calandra-battersby
  • 26 Slides

attraverso . i . c. asi clinici. Giuseppe . Valma...

Estimated costs of managing treatment-related adverse

Estimated costs of managing treatment-related adverse

  • lindy-dunigan
  • 8 Slides

eventsof. . nivolumab. and . docetaxel. in the...

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

  • olivia-moreira
  • 32 Slides

Low TPS High TPS TPS = PD-L1 tumor proportion sco...

ASCO 2019 NSCLC - PARP & Chemotherapy

ASCO 2019 NSCLC - PARP & Chemotherapy

  • mitsue-stanley
  • 12 Slides

ASCO 2019 NSCLC - PARP & Chemotherapy REF Stu...

OMICS International welcomes submissions that are original and technically so as to serve both th

OMICS International welcomes submissions that are original and technically so as to serve both th

  • lois-ondreau
  • 0 Slides

OMICS Journals are poised in excellence by publi...

Lung cancer Treatment

Lung cancer Treatment

  • attentionallianz
  • 20 Slides

Consequences of the Lack of Patients of color &...

Module 13: Targeted Treatment

Module 13: Targeted Treatment

  • disclaimercanon
  • 49 Slides

of Lung Cancer . Wendi S Lee, MSN, RN, NP-C. Anne ...

Please note, these are the

Please note, these are the

  • vizettan
  • 84 Slides

actual. . video-recorded proceedings from the . l...

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

  • singh
  • 95 Slides

1 Study Title: Neoadjuvant Nivolumab, or Nivoluma...

Presented at the European Society for Medical Oncology 2019 Barcelona

Presented at the European Society for Medical Oncology 2019 Barcelona

  • lucy
  • 1 Slides

– 1 October, 2019 ● GSK 3377794 activate and i...

Instructions for Use of These Slides

Instructions for Use of These Slides

  • carla
  • 58 Slides

The purpose of these slides is to serve as a resou...

Copyright © 2024 DocSlides. All Rights Reserved